A Digital Health Unicorn Goes Bankrupt, and FDA revokes a COVID-19 Test. But first, the latest on Second Sight’s unfortunate end.

Bigfoot raises $55M, and AdvaMed CEO Scott Whitaker takes a stand against racial injustice. But first, what the heck is the Fitbit Flow?

NFL helmets are getting a major COVID-19 makeover, and Roche companies are shaking things up in lung cancer trials. But first, we’ll talk about Apple and Google’s contact tracing tech.

Your time is valuable, so we’ve drilled down the three most important medtech stories of the week so you can get back to your Zoom meetings and Quarantine-Casual Friday.

Abbott Laboratories just released a statement defending its test after the accuracy of the test was questioned by a recent NYU study.

Your time is valuable — yes, even now — so we’ve drilled down the three most important medtech stories of the week so that you can get back to your Zoom meetings and quarantine-casual Friday.

Your time is valuable — yes, even now — so we’ve drilled down the three most important medtech stories of the week so that you can get back to your Zoom meetings and quarantine-casual Friday.